Neprilysin regulates amyloid Beta peptide levels - PubMed (original) (raw)
Neprilysin regulates amyloid Beta peptide levels
Robert A Marr et al. J Mol Neurosci. 2004.
Abstract
That neprilysin (NEP) is a major Abeta peptide-degrading enzyme in vivo is shown by higher Abeta peptide levels in the brain of an NEP knockout mouse. In addition, we show that infusion of an NEPinhibitor, but not inhibitors of other peptidases, into the brains of an APP transgenic mouse elevates Abeta levels. We have investigated the use of NEP as a potential therapeutic agent to prevent the accumulation of Abeta peptides in the brain. Lentivirus expressing NEP was initially used to demonstrate the ability of the enzyme to reduce Abeta levels in a model CHO cell line and to make primary hippocampal neurons resistant to Abeta-mediated neurotoxicity. Injection of NEPexpressing lentivirus, but not inactive NEP-expressing lentivirus, GFP-expressing lentivirus, or vehicle, into the hippocampus of 12-20-mo-old hAPP transgenic mice led to an approx 50% reduction in the number of amyloid plaques. These studies provide the impetus for further investigating of the use of NEP in a gene transfer therapy paradigm to prevent the accumulation of Abeta and prevent or delay the onset of Alzheimer's disease.
Similar articles
- Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O, Selkoe DJ. Hemming ML, et al. PLoS Med. 2007 Aug;4(8):e262. doi: 10.1371/journal.pmed.0040262. PLoS Med. 2007. PMID: 17760499 Free PMC article. - Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E. Marr RA, et al. J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003. J Neurosci. 2003. PMID: 12657655 Free PMC article. - Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, Cheng IH, Yu GQ, Mucke L. Meilandt WJ, et al. J Neurosci. 2009 Feb 18;29(7):1977-86. doi: 10.1523/JNEUROSCI.2984-08.2009. J Neurosci. 2009. PMID: 19228952 Free PMC article. - [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M, Kawakubo T, Mori R, Iwata N. Asai M, et al. Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese. - Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
Miners JS, Barua N, Kehoe PG, Gill S, Love S. Miners JS, et al. J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46. J Neuropathol Exp Neurol. 2011. PMID: 22002425 Review.
Cited by
- APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L, Rockenstein E, Masliah E. Crews L, et al. Brain Struct Funct. 2010 Mar;214(2-3):111-26. doi: 10.1007/s00429-009-0232-6. Epub 2009 Nov 29. Brain Struct Funct. 2010. PMID: 20091183 Free PMC article. Review. - RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis.
Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MB. Ward SV, et al. Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):331-6. doi: 10.1073/pnas.1017241108. Epub 2010 Dec 20. Proc Natl Acad Sci U S A. 2011. PMID: 21173229 Free PMC article. - N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells.
Wang R, Malter JS, Wang DS. Wang R, et al. J Alzheimers Dis. 2010;19(1):179-89. doi: 10.3233/JAD-2010-1226. J Alzheimers Dis. 2010. PMID: 20061637 Free PMC article. - The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin.
Lim CS, Han JS. Lim CS, et al. Biosci Rep. 2018 Feb 2;38(1):BSR20171611. doi: 10.1042/BSR20171611. Print 2018 Feb 28. Biosci Rep. 2018. PMID: 29330223 Free PMC article. - Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors.
Nathanson JL, Yanagawa Y, Obata K, Callaway EM. Nathanson JL, et al. Neuroscience. 2009 Jun 30;161(2):441-50. doi: 10.1016/j.neuroscience.2009.03.032. Epub 2009 Mar 24. Neuroscience. 2009. PMID: 19318117 Free PMC article.
References
- Adv Drug Deliv Rev. 2002 Dec 7;54(12):1603-13 - PubMed
- Curr Pharm Des. 2003;9(6):449-54 - PubMed
- J Neurosci. 2003 Jan 1;23(1):29-33 - PubMed
- Brain Res. 2001 Nov 16;919(1):115-21 - PubMed
- J Neurosci Res. 2001 Nov 15;66(4):573-82 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AG05131/AG/NIA NIH HHS/United States
- AG10689/AG/NIA NIH HHS/United States
- AG18440/AG/NIA NIH HHS/United States
- AG19323/AG/NIA NIH HHS/United States
- DA02243/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials